{"id":62429,"date":"2026-01-01T16:05:57","date_gmt":"2026-01-01T15:05:57","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/cell-gene-therapies-in-respiratory-disorders-therapeutic-analysis-report-2025-landscape-is-currently-in-the-early-stages-of-development-with-no-marketed-cgts-to-date-researchandmarkets-com\/"},"modified":"2026-01-01T16:05:57","modified_gmt":"2026-01-01T15:05:57","slug":"cell-gene-therapies-in-respiratory-disorders-therapeutic-analysis-report-2025-landscape-is-currently-in-the-early-stages-of-development-with-no-marketed-cgts-to-date-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/cell-gene-therapies-in-respiratory-disorders-therapeutic-analysis-report-2025-landscape-is-currently-in-the-early-stages-of-development-with-no-marketed-cgts-to-date-researchandmarkets-com\/","title":{"rendered":"Cell &amp; Gene Therapies in Respiratory Disorders Therapeutic Analysis Report 2025: Landscape is Currently in the Early Stages of Development, with No Marketed CGTs to Date. &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/6214903\/cell-and-gene-therapies-in-respiratory-disorders?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=pmrmmj&amp;utm_campaign=2125112+-+Cell+%26+Gene+Therapies+in+Respiratory+Disorders+Therapeutic+Analysis+Report+2025%3A+Landscape+is+Currently+in+the+Early+Stages+of+Development%2C+with+No+Marketed+CGTs+to+Date.&amp;utm_exec=chdomspi\" rel=\"nofollow\" shape=\"rect\">&#8220;Cell &amp; Gene Therapies in Respiratory Disorders: Therapeutic Analysis&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20260101453717\/en\/2680445\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260101453717\/en\/2680445\/22\/logo.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20260101453717\/en\/2680445\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260101453717\/en\/2680445\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe cell and gene therapies (CGTs) landscape for respiratory diseases is currently in the early stages of development, with no marketed CGTs to date.<\/p>\n<p>\n<strong>Reasons to Buy<\/strong><\/p>\n<ul>\n<li>\nDevelop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.<\/li>\n<li>\nDevelop business strategies by understanding the trends shaping and driving the CGT in Respiratory market.<\/li>\n<li>\nDrive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact Respiratory disease targeting CGT therapeutics market in the future.<\/li>\n<li>\nIdentify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.<\/li>\n<li>\nOrganize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong><\/p>\n<p>\n<strong>1. Preface<br \/>\n<br \/><\/strong>1.1. Contents<br \/>\n<br \/>1.2. Abbreviations<br \/>\n<br \/>1.3. Related Reports<\/p>\n<p>\n<strong>2. Executive Summary<\/strong><\/p>\n<p>\n<strong>3. Introduction and Scope<\/strong><\/p>\n<p>\n<strong>4. Current Treatment Options<br \/>\n<br \/><\/strong>4.1. What is Cell &amp; Gene Therapy?<br \/>\n<br \/>4.2. History of the Development of CGT in Respiratory Disorders<\/p>\n<p>\n<strong>5. Unmet Needs<br \/>\n<br \/><\/strong>5.1. Challenges and Opportunities in CGT in Respiratory Disorders<\/p>\n<p>\n<strong>6. Regulations<br \/>\n<br \/><\/strong>6.1. Regulation of CGTs in the 8MM<\/p>\n<p>\n<strong>7. Future Market Assessment<br \/>\n<br \/><\/strong>7.1. Top 20 Respiratory Disorders with CGT Development<br \/>\n<br \/>7.2. Top Five Respiratory Disorders with the Most CGT Pipeline Assets<br \/>\n<br \/>7.3. Top Five Respiratory Disorders Stratified by Molecule Type<br \/>\n<br \/>7.4. CGT in Respiratory Disorders -Phase II\/III<br \/>\n<br \/>7.5. Industry Trends in the Application of CGTs in Respiratory Disorders<br \/>\n<br \/>7.6. CGT Market Catalyst are limited to a single company in the next 5 years<\/p>\n<p>\n<strong>8. Likelihood of Approval and Phase &#8211; Transition Success Rate Analysis<br \/>\n<br \/><\/strong>8.1. CGT Candidates Have Lower PTSR vs. Indication Benchmarks<\/p>\n<p>\n<strong>9. Sales Forecast<br \/>\n<br \/><\/strong>9.1. Sales are forecast to reach $62 million by 2030<\/p>\n<p>\n<strong>10. Appendix<\/strong><\/p>\n<p>\n<strong>Companies Featured<\/strong><\/p>\n<ul>\n<li>\nVertex Pharmaceuticals Inc<\/li>\n<li>\nMediPost Co Ltd<\/li>\n<li>\nKYORIN Pharmaceuticals Co Ltd<\/li>\n<li>\nBonus BioGroup Ltd<\/li>\n<li>\nArmata Pharmaceuticals Ltd<\/li>\n<li>\nTranslate Bio Inc<\/li>\n<li>\n4D Molecular Therapeutics Inc<\/li>\n<li>\nSuzhou Regend Therapeutics Co Ltd<\/li>\n<li>\nMiNK Therapeutics Inc<\/li>\n<li>\nHuman Life CORD Japan Inc<\/li>\n<li>\nNuwacell Biotechnology Co Ltd<\/li>\n<li>\nTaskin Bioregeneration Co<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/6214903\/cell-and-gene-therapies-in-respiratory-disorders?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=pmrmmj&amp;utm_campaign=2125112+-+Cell+%26+Gene+Therapies+in+Respiratory+Disorders+Therapeutic+Analysis+Report+2025%3A+Landscape+is+Currently+in+the+Early+Stages+of+Development%2C+with+No+Marketed+CGTs+to+Date.&amp;utm_exec=chdomspi\" rel=\"nofollow\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/f94g3w<\/a><\/p>\n<p>\n<strong>About ResearchAndMarkets.com<br \/>\n<br \/><\/strong>ResearchAndMarkets.com is the world&#8217;s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#105;&#108;&#116;o&#x3a;&#x70;&#x72;&#101;&#115;s&#64;&#x72;&#x65;&#x73;&#101;&#97;r&#x63;&#x68;&#x61;&#110;&#100;&#109;a&#x72;&#x6b;&#x65;&#116;&#115;&#46;c&#x6f;&#x6d;\" rel=\"nofollow\" shape=\"rect\">&#x70;&#114;e&#x73;&#115;&#64;&#x72;&#101;s&#x65;&#x61;&#114;&#x63;&#x68;&#97;n&#x64;&#109;a&#x72;&#107;e&#x74;&#x73;&#46;&#x63;&#x6f;&#109;<\/a><\/p>\n<p>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Cell &amp; Gene Therapies in Respiratory Disorders: Therapeutic Analysis&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The cell and gene therapies (CGTs) landscape for respiratory diseases is currently in the early stages of development, with no marketed CGTs to date. Reasons to Buy Develop and design your in-licensing and out-licensing strategies through a &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/cell-gene-therapies-in-respiratory-disorders-therapeutic-analysis-report-2025-landscape-is-currently-in-the-early-stages-of-development-with-no-marketed-cgts-to-date-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62429","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cell &amp; Gene Therapies in Respiratory Disorders Therapeutic Analysis Report 2025: Landscape is Currently in the Early Stages of Development, with No Marketed CGTs to Date. - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/cell-gene-therapies-in-respiratory-disorders-therapeutic-analysis-report-2025-landscape-is-currently-in-the-early-stages-of-development-with-no-marketed-cgts-to-date-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cell &amp; Gene Therapies in Respiratory Disorders Therapeutic Analysis Report 2025: Landscape is Currently in the Early Stages of Development, with No Marketed CGTs to Date. - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Cell &amp; Gene Therapies in Respiratory Disorders: Therapeutic Analysis&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The cell and gene therapies (CGTs) landscape for respiratory diseases is currently in the early stages of development, with no marketed CGTs to date. Reasons to Buy Develop and design your in-licensing and out-licensing strategies through a ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/cell-gene-therapies-in-respiratory-disorders-therapeutic-analysis-report-2025-landscape-is-currently-in-the-early-stages-of-development-with-no-marketed-cgts-to-date-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-01T15:05:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20260101453717\/en\/2680445\/22\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cell-gene-therapies-in-respiratory-disorders-therapeutic-analysis-report-2025-landscape-is-currently-in-the-early-stages-of-development-with-no-marketed-cgts-to-date-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cell-gene-therapies-in-respiratory-disorders-therapeutic-analysis-report-2025-landscape-is-currently-in-the-early-stages-of-development-with-no-marketed-cgts-to-date-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Cell &amp; Gene Therapies in Respiratory Disorders Therapeutic Analysis Report 2025: Landscape is Currently in the Early Stages of Development, with No Marketed CGTs to Date. &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2026-01-01T15:05:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cell-gene-therapies-in-respiratory-disorders-therapeutic-analysis-report-2025-landscape-is-currently-in-the-early-stages-of-development-with-no-marketed-cgts-to-date-researchandmarkets-com\\\/\"},\"wordCount\":459,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cell-gene-therapies-in-respiratory-disorders-therapeutic-analysis-report-2025-landscape-is-currently-in-the-early-stages-of-development-with-no-marketed-cgts-to-date-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260101453717\\\/en\\\/2680445\\\/22\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cell-gene-therapies-in-respiratory-disorders-therapeutic-analysis-report-2025-landscape-is-currently-in-the-early-stages-of-development-with-no-marketed-cgts-to-date-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cell-gene-therapies-in-respiratory-disorders-therapeutic-analysis-report-2025-landscape-is-currently-in-the-early-stages-of-development-with-no-marketed-cgts-to-date-researchandmarkets-com\\\/\",\"name\":\"Cell &amp; Gene Therapies in Respiratory Disorders Therapeutic Analysis Report 2025: Landscape is Currently in the Early Stages of Development, with No Marketed CGTs to Date. - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cell-gene-therapies-in-respiratory-disorders-therapeutic-analysis-report-2025-landscape-is-currently-in-the-early-stages-of-development-with-no-marketed-cgts-to-date-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cell-gene-therapies-in-respiratory-disorders-therapeutic-analysis-report-2025-landscape-is-currently-in-the-early-stages-of-development-with-no-marketed-cgts-to-date-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260101453717\\\/en\\\/2680445\\\/22\\\/logo.jpg\",\"datePublished\":\"2026-01-01T15:05:57+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cell-gene-therapies-in-respiratory-disorders-therapeutic-analysis-report-2025-landscape-is-currently-in-the-early-stages-of-development-with-no-marketed-cgts-to-date-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cell-gene-therapies-in-respiratory-disorders-therapeutic-analysis-report-2025-landscape-is-currently-in-the-early-stages-of-development-with-no-marketed-cgts-to-date-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cell-gene-therapies-in-respiratory-disorders-therapeutic-analysis-report-2025-landscape-is-currently-in-the-early-stages-of-development-with-no-marketed-cgts-to-date-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260101453717\\\/en\\\/2680445\\\/22\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260101453717\\\/en\\\/2680445\\\/22\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cell-gene-therapies-in-respiratory-disorders-therapeutic-analysis-report-2025-landscape-is-currently-in-the-early-stages-of-development-with-no-marketed-cgts-to-date-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cell &amp; Gene Therapies in Respiratory Disorders Therapeutic Analysis Report 2025: Landscape is Currently in the Early Stages of Development, with No Marketed CGTs to Date. &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cell &amp; Gene Therapies in Respiratory Disorders Therapeutic Analysis Report 2025: Landscape is Currently in the Early Stages of Development, with No Marketed CGTs to Date. - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/cell-gene-therapies-in-respiratory-disorders-therapeutic-analysis-report-2025-landscape-is-currently-in-the-early-stages-of-development-with-no-marketed-cgts-to-date-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Cell &amp; Gene Therapies in Respiratory Disorders Therapeutic Analysis Report 2025: Landscape is Currently in the Early Stages of Development, with No Marketed CGTs to Date. - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Cell &amp; Gene Therapies in Respiratory Disorders: Therapeutic Analysis&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The cell and gene therapies (CGTs) landscape for respiratory diseases is currently in the early stages of development, with no marketed CGTs to date. Reasons to Buy Develop and design your in-licensing and out-licensing strategies through a ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/cell-gene-therapies-in-respiratory-disorders-therapeutic-analysis-report-2025-landscape-is-currently-in-the-early-stages-of-development-with-no-marketed-cgts-to-date-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2026-01-01T15:05:57+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20260101453717\/en\/2680445\/22\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/cell-gene-therapies-in-respiratory-disorders-therapeutic-analysis-report-2025-landscape-is-currently-in-the-early-stages-of-development-with-no-marketed-cgts-to-date-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/cell-gene-therapies-in-respiratory-disorders-therapeutic-analysis-report-2025-landscape-is-currently-in-the-early-stages-of-development-with-no-marketed-cgts-to-date-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Cell &amp; Gene Therapies in Respiratory Disorders Therapeutic Analysis Report 2025: Landscape is Currently in the Early Stages of Development, with No Marketed CGTs to Date. &#8211; ResearchAndMarkets.com","datePublished":"2026-01-01T15:05:57+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/cell-gene-therapies-in-respiratory-disorders-therapeutic-analysis-report-2025-landscape-is-currently-in-the-early-stages-of-development-with-no-marketed-cgts-to-date-researchandmarkets-com\/"},"wordCount":459,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/cell-gene-therapies-in-respiratory-disorders-therapeutic-analysis-report-2025-landscape-is-currently-in-the-early-stages-of-development-with-no-marketed-cgts-to-date-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260101453717\/en\/2680445\/22\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/cell-gene-therapies-in-respiratory-disorders-therapeutic-analysis-report-2025-landscape-is-currently-in-the-early-stages-of-development-with-no-marketed-cgts-to-date-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/cell-gene-therapies-in-respiratory-disorders-therapeutic-analysis-report-2025-landscape-is-currently-in-the-early-stages-of-development-with-no-marketed-cgts-to-date-researchandmarkets-com\/","name":"Cell &amp; Gene Therapies in Respiratory Disorders Therapeutic Analysis Report 2025: Landscape is Currently in the Early Stages of Development, with No Marketed CGTs to Date. - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/cell-gene-therapies-in-respiratory-disorders-therapeutic-analysis-report-2025-landscape-is-currently-in-the-early-stages-of-development-with-no-marketed-cgts-to-date-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/cell-gene-therapies-in-respiratory-disorders-therapeutic-analysis-report-2025-landscape-is-currently-in-the-early-stages-of-development-with-no-marketed-cgts-to-date-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260101453717\/en\/2680445\/22\/logo.jpg","datePublished":"2026-01-01T15:05:57+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/cell-gene-therapies-in-respiratory-disorders-therapeutic-analysis-report-2025-landscape-is-currently-in-the-early-stages-of-development-with-no-marketed-cgts-to-date-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/cell-gene-therapies-in-respiratory-disorders-therapeutic-analysis-report-2025-landscape-is-currently-in-the-early-stages-of-development-with-no-marketed-cgts-to-date-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/cell-gene-therapies-in-respiratory-disorders-therapeutic-analysis-report-2025-landscape-is-currently-in-the-early-stages-of-development-with-no-marketed-cgts-to-date-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20260101453717\/en\/2680445\/22\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20260101453717\/en\/2680445\/22\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/cell-gene-therapies-in-respiratory-disorders-therapeutic-analysis-report-2025-landscape-is-currently-in-the-early-stages-of-development-with-no-marketed-cgts-to-date-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Cell &amp; Gene Therapies in Respiratory Disorders Therapeutic Analysis Report 2025: Landscape is Currently in the Early Stages of Development, with No Marketed CGTs to Date. &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62429","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62429"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62429\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62429"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62429"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62429"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}